TuHURA Biosciences, Inc. 8-K Report: Key Developments on December 27, 2024

Based on the provided section of the financial report, here are the key pieces of information extracted:

Entity Information:

Company Name: TuHURA Biosciences, Inc.
State of Incorporation: Nevada (NV)
CIK (Central Index Key): 0001498382
IRS Employer Identification Number: 99-0360497
Address: 10500 University Center Dr., Suite 110, Tampa, FL 33612
Contact Number: (813) 875-6600

Report Type and Filing Date:

Form Type: 8-K (a report of unscheduled material events or corporate changes)
Filing Date: December 27, 2024

Stock Information:

Common Stock: Par value of $0.001 per share
Ticker Symbol: HURA
Exchange: NASDAQ

Reporting Context:

Period Covered: The report pertains to a single day, December 27, 2024.

Schema Reference:

The document references a schema file: hura-20241227.xsd, indicating it follows a structured format for XBRL (eXtensible Business Reporting Language) reporting.

Insights:

This report is a current event filing (Form 8-K), which suggests that TuHURA Biosciences, Inc. may have experienced a significant event that necessitated immediate disclosure to investors and the SEC.
The single-day reporting period indicates that this filing is likely related to a specific event that occurred on that date, rather than a detailed quarterly or annual performance report.
The presence of common stock listed on NASDAQ indicates that the company is publicly traded, which subjects it to regular reporting and governance standards.

This information is crucial for investors and analysts monitoring the company's performance and any potential impacts on its stock due to the events reported in the 8-K filing.